Stock KRMD KORU MEDICAL SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News KORU Medical Systems, Inc.

Equities

KRMD

US7599101026

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-19 pm EDT 		5-day change 1st Jan Change
2.08 USD +0.97% Intraday chart for KORU Medical Systems, Inc. 0.00% -15.27%
Mar. 13 Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Mar. 13 KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
BU
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
BU
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
BU
Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024
KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M
MT
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
BU
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024
CI
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
BU
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic
CI
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
BU
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin
CI
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
BU
KORU Medical : Investor Day 2023 Presentation
PU
Transcript : KORU Medical Systems, Inc. - Analyst/Investor Day
KORU Medical Systems to Participate in Piper Sandler's 35th Annual Healthcare Conference
AQ
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference
BU
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KRMD Stock
  4. News KORU Medical Systems, Inc.